2,4,6,8,10,12,14-Pentadecaheptaenoic acid,15-(3-hydroxy-2-methylphenyl)-, methyl ester,(2E,4E,6E,8E,10E,12E,14E)- (800390-17-4)

Identification
Name:	2,4,6,8,10,12,14-Pentadecaheptaenoic acid,15-(3-hydroxy-2-methylphenyl)-, methyl ester,(2E,4E,6E,8E,10E,12E,14E)-
CAS:	800390-17-4
Molecular Formula:	C₂₃H₂₄O₃
Molecular Structure:
Properties
Safety Data

Other Product

2,4,6,8,10,12,14-Pentadecaheptaenoic acid,15-(4-chloro-3-hydroxy-2-methylphenyl)-, methyl ester,(2E,4E,6E,8E,10E,12E,14E)-
2,4,6,8,10,12,14-Hexadecaheptaenedial,(2E,4E,6E,8E,10E,12E,14E)-
2,4,6,8,10,12,14,16-Octadecaoctaene,(2E,4E,6E,8E,10E,12E,14E,16E)-
2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid,17-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-2,6,11,15-tetramethyl-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
2,4,6,8,10,12,14,16-Octadecaoctaen-1-one,17-[(2S,6S,7aR)-2,4,5,6,7,7a-hexahydro-6-hydroxy-4,4,7a-trimethyl-2-benzofuranyl]-1-[(1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13-trimethyl-,(2E,4E,6E,8E,10E,12E,14E,16E)-
(2E,4E,6E,8E,10E,12E,14E)-4,9,13,17,17-Pentamethyl-16,21-dioxo-2,4,6,8,10,12,14-docosaheptaenoic acid
2,4,6,8,10,12,14-Hexadecaheptaenedioic acid, 2,6,11,15-tetramethyl-,sodium salt, (2E,4E,6E,8E,10E,12E,14E)-
2,4,6,8,10,12,14,16,18,20,22-Tricosaundecaenal,23-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-4,8,12,17,21-pentamethyl-,(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)- (9CI)
2,4,6,8,10,12-Tetradecahexaenal,14-[(1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl]-2,7,11-trimethyl-14-oxo-, (2E,4E,6E,8E,10E,12E)-
2,4,6,8,10,12,14-Hexadecaheptaenediamide,N,N'-bis(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-, (2E,4E,6E,8E,10E,12E,14E)- (9CI)
2,4,6,8,10,12,14-Pentadecaheptaenal,4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E)-
L-Glutamic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S)-1-carboxy-2-methylpropyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
4,6,8,10,12,14,16,18,22-Tetracosanonaen-2-ol,2,6,10,15,19,23-hexamethyl-, (4E,6E,8E,10E,12E,14E,16E,18E)-
2,4,6,8,10,12,14,16,18-Eicosanonaenedioicacid, 4,8,13,17-tetramethyl-, 1-methyl ester,(2E,4Z,6E,8E,10E,12E,14E,16E,18E)-
2,4,6,8,10,12-Tridecahexaenoicacid, 3-hydroxy-2,12-dimethyl-13-phenyl-, methyl ester, (2Z,4E,6E,8E,10E,12E)-
4,6,8,10,12,14,16,18,20,22,24,26,30-Dotriacontatridecaen-2-ol,2,6,10,14,19,23,27,31-octamethyl-3-(3-methyl-2-buten-1-yl)-, (3S,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-
b-D-Glucopyranose, 1-[hydrogen(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate],6'-ester with 2-b-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one(9CI)
(2E,4E,6E,8E,10E,12E)-tetracosa-2,4,6,8,10,12-hexaenoic acid